Fundraising Fox

Rebalance Health

Boulder, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

SL
Scott L. GlennTreasurer
CL
Charles L. KloerisSecretary
RL
Randy L. HetrickDirector
JA
Justin A. HaiPresident and Chief Executive Officer
JL
James L. Breitmeyer, M.D., Ph.D.Director
PL
Patrick L. HopfDirector

Reported raises · per SEC filings

Form D private placements
▶$7.4MraisedAug 2023 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott L. GlennExecutive Officer, Director
  • Randy A. HetrickDirector
  • Fabian C. SeelbachDirector
  • Mark C. McKennaDirector
  • Patrick A. HopfDirector
  • James B. BreitmeyerDirector
  • Justin A. HaiExecutive Officer, Director
Offering amount
$10M
Amount sold
$7.4M
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedMay 2022 · 68 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Justin A. HaiExecutive Officer, Director
  • Patrick A. HopfDirector
  • Scott L. GlennExecutive Officer, Director
  • Mark C. McKennaDirector
  • Fabian C. SellbachDirector
  • Randy A. HetrickDirector
  • James B. BreitmeyerDirector
Offering amount
$10M
Amount sold
$7.6M
First sale
Feb 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedNov 2021 · 96 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott L. GlennDirector, Executive Officer
  • Charles L. KloerisDirector, Executive Officer
  • Randy L. HetrickDirector
  • Justin A. HaiDirector, Executive Officer
  • James L. Breitmeyer, M.D., Ph.D.Director
  • Patrick L. HopfDirector
Offering amount
$6.7M
Amount sold
$6.7M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.